70868-820 : Desoxyn 5 mg Oral Tablet

NDC:	70868-820
Labeler:	Key Therapeutics
Product Type:	Human Prescription Drug
Drug Name:	Desoxyn
Dosage Form:	Oral Tablet
Application #:	NDA005378
Rev. Date:	Sep 1, 2022
CSA Schedule:	CII (US) [1]

^[1] Schedule II / IIN Controlled Substance: High potential for abuse which may lead to severe psychological or physical dependence. (i.e. Narcotics such as Dilaudid, Methadone, Demerol, Oxycodone, Percocet, Fentanyl, Morphine, Opium, Codeine, and Hydrocodone ... Schedule IIN stimulants include non-narcotic Amphetamines such as Dexedrine, Adderall, Desoxyn, Methylphenidate (Ritalin) ... Other Schedule II substances include Amobarbital, Glutethimide, and Pentobarbital. More Details: US Dept of Justice Controlled Substance Schedules.

NDC Package Codes:

• 70868-820-05: 100 TABLET IN 1 BOTTLE (70868‑820‑05)

Active Ingredients:

• Methamphetamine Hydrochloride

Pharmaceutical Classes:

• Amphetamine Anorectic [EPC]
• Amphetamines [CS]
• Appetite Suppression [PE]
• Central Nervous System Stimulant [EPC]
• Central Nervous System Stimulation [PE]
• Increased Sympathetic Activity [PE]

Related Products:

Based on records with the same trade name.

• 55292-102 Desoxyn 5 mg Oral Tablet by Recordati Rare Diseases, Inc.
• 55292-104 Desoxyn 5 mg Oral Tablet by Recordati Rare Diseases, Inc.
• 67386-102 Desoxyn 5 mg Oral Tablet by Lundbeck Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:



< Prev: 70868-810Next: 70868-901 >

Related Discussions: